Skye Bioscience Inc (SKYE)
5.53
+0.21
(+3.95%)
USD |
NASDAQ |
Nov 14, 16:00
5.53
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Total Assets (Quarterly): 81.54M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 81.54M |
| June 30, 2024 | 87.26M |
| March 31, 2024 | 94.84M |
| December 31, 2023 | 11.94M |
| September 30, 2023 | 15.60M |
| June 30, 2023 | 2.236M |
| March 31, 2023 | 4.587M |
| December 31, 2022 | 9.111M |
| September 30, 2022 | 2.869M |
| June 30, 2022 | 4.968M |
| March 31, 2022 | 7.211M |
| December 31, 2021 | 9.855M |
| September 30, 2021 | 11.69M |
| June 30, 2021 | 5.488M |
| March 31, 2021 | 5.399M |
| December 31, 2020 | 2.672M |
| September 30, 2020 | 4.350M |
| June 30, 2020 | 0.2272M |
| March 31, 2020 | 0.673M |
| December 31, 2019 | 1.997M |
| September 30, 2019 | 1.725M |
| June 30, 2019 | 3.080M |
| March 31, 2019 | 4.725M |
| December 31, 2018 | 1.957M |
| Date | Value |
|---|---|
| September 30, 2018 | 1.166M |
| June 30, 2018 | 2.042M |
| March 31, 2018 | 3.158M |
| December 31, 2017 | 0.5572M |
| September 30, 2017 | 0.343M |
| June 30, 2017 | 0.484M |
| March 31, 2017 | 0.6174M |
| December 31, 2016 | 0.3234M |
| September 30, 2016 | 0.6921M |
| June 30, 2016 | 1.081M |
| March 31, 2016 | 2.350M |
| December 31, 2015 | 3.511M |
| September 30, 2015 | 4.542M |
| June 30, 2015 | 0.8208M |
| March 31, 2015 | 0.4687M |
| December 31, 2014 | 0.3483M |
| September 30, 2014 | 1.126M |
| July 31, 2014 | 0.1676M |
| April 30, 2014 | 0.1227M |
| January 31, 2014 | 0.1408M |
| October 31, 2013 | 0.1457M |
| July 31, 2013 | 0.129M |
| April 30, 2013 | 0.1344M |
| October 31, 2012 | 0.0429M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.2272M
Minimum
Jun 2020
94.84M
Maximum
Mar 2024
18.23M
Average
5.443M
Median
Total Assets (Quarterly) Benchmarks
| Oramed Pharmaceuticals Inc | 184.22M |
| Viking Therapeutics Inc | 937.89M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.732M |
| Shareholders Equity (Quarterly) | 75.80M |